Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2010 | 07-2007 | |
| Operating Expenses | 317 | 0 |
| Operating Income | -317 | N/A |
| Other Income | -562 | 0 |
| Pre-tax Income | -879 | 0 |
| Net Income Continuous | -879 | N/A |
| Net Income | $-879 | $N/A |
| EPS Basic Total Ops | -2,154.87 | N/A |
| EPS Basic Continuous Ops | -2,252.66 | N/A |
| EPS Diluted Total Ops | -2,154.87 | N/A |
| EPS Diluted Continuous Ops | -2,252.66 | N/A |
| EBITDA(a) | $-315 | $N/A |